2Nadler RB,Loeb S,Kimberly AR,et al. use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years[J]. J Urol,2005,174(1),2154. 被引量：1
3Gilbert SM, Christina BC, Kahane H, et al. Evedence suggesting PSA cutpoint of 2.5 nl/ml for prompting prostate biopsy: review of 36,316 biopsies[J]. Urol,2005,65(1) :549. 被引量：1
4Terris M K,S tam ey TA. D eterm ination of prostate volume by transreetal ultrasdound[J]. J Urol, 1991 (1), 145 : 984. 被引量：1
6Sfoungristos S,Perimenis P. PSA dengsity is superior than PSA and Gleason score for adverse pathologic features prediction in pa- tients with clinically localized prostate cancer[J]. Can Urol Assoc J,2012,6(1):46. 被引量：1
7Gretzer MB.Partin AW.PSA markers in prostate cancer detection[J].Urol Clin N Am,2003,30:677-686. 被引量：1
8Thompson IM,Pauler DK,Goodman Pl,et al.Prevalence of prostate cancer among men with a prostate-specific antigen level 《 or =4.0 ng per milliliter[J].N Engl J Med 2004,350:2239-2246. 被引量：1
9Thakur V,Singh PP,Talware M,et al.Utility of free/total prostate specific antigen(f/t PSA)ratio in diagnosis of prostate carcinoma[J].Dis Markers(2003,2004),19:287-292. 被引量：1
10Espana F,Martinez M,Royo M,et al.Changes in molecular forms of prostate-specific antigen during treatment with finasteride[J].BJU International,2002.90:672-677. 被引量：1
